Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
escitalopram bluefish filmuhúðuð tafla 15 mg
bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 15 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
finasteride medical valley filmuhúðuð tafla 5 mg
medical valley invest ab - finasteridum inn - filmuhúðuð tafla - 5 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
mycofenolsýra accord (mycofenolsýra accord healthcare) magasýruþolin tafla 180 mg
accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 180 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
mycofenolsýra accord (mycofenolsýra accord healthcare) magasýruþolin tafla 360 mg
accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 360 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
valaciclovir bluefish filmuhúðuð tafla 500 mg
bluefish pharmaceuticals ab - valaciclovirum hýdróklóríð - filmuhúðuð tafla - 500 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxine bluefish hart forðahylki 150 mg
bluefish pharmaceuticals ab - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxine bluefish hart forðahylki 37,5 mg
bluefish pharmaceuticals ab - venlafaxinum hýdróklóríð - hart forðahylki - 37,5 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxine bluefish hart forðahylki 75 mg
bluefish pharmaceuticals ab - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg
Eiropas Savienība -
īslandiešu -
EMA (European Medicines Agency)
dabigatran etexilate accord
accord healthcare s.l.u. - dabigatran etexilate mesilate - venous thromboembolism; arthroplasty, replacement - blóðþurrðandi lyf - prevention of venous thromboembolic events.
Eiropas Savienība -
īslandiešu -
EMA (European Medicines Agency)
tolvaptan accord
accord healthcare s.l.u. - tolvaptan - Óviðeigandi adh heilkenni - Þvagræsilyf, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).